Page last updated: 2024-12-06

tingenin b

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

tingenin B: isolated from Glyptopetalum sclerocarpaum; structure given in first source; RN given refers to (20beta,22beta)-isomer; RN for cpd without isomeric designation not available 11/90; RN is for tingenin A (8/2001) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
GlyptopetalumgenusA plant genus of the family Celastraceae that contains glyptopetolide (ursane-type triterpene), sclerocarpic acid, (sesquiterpene), hydroxytingenone, isoarborinol and cangoronine (triterpenoids).[MeSH]CelastraceaeA plant family of the order Celastrales, subclass Rosidae, class Magnoliopsida.[MeSH]

Cross-References

ID SourceID
PubMed CID73147
SCHEMBL ID20957640
MeSH IDM0181694

Synonyms (11)

Synonym
22-hydroxytingenone
50656-68-3
(6as,6bs,8ar,9s,11r,12as,14ar)-3,9-dihydroxy-4,6a,6b,8a,11,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydropicene-2,10-dione
24,25,26,30-tetranoroleana-1(10),3,5,7-tetraene-2,21-dione,3,22-dihydroxy-9,13-dimethyl-,(9.beta.,13.alpha.,14.beta,20.beta.,22.beta.)-
tingenin b
d:a-friedo-24,30-dinoroleana-1(10),3,5,7-tetraene-2,21-dione, 3,22-dihydroxy-, (20beta,22beta)-
24,25,26,30-tetranoroleana-1(10),3,5,7-tetraene-2,21-dione,3,22-dihydroxy-9,13-dimethyl-, (9b,13a,14b,20b,22b)-
SCHEMBL20957640
DTXSID80964893
3,9-dihydroxy-4,6b,8a,11,12b,14a-hexamethyl-7,8,8a,11,12,12a,12b,13,14,14a-decahydropicene-2,10(6bh,9h)-dione
AKOS040746410
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)IC50 (µMol)7.00000.00041.877310.0000AID356411
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (13)

Assay IDTitleYearJournalArticle
AID356411Inhibition of aldose reductase in rat lens homogenate2003Journal of natural products, Sep, Volume: 66, Issue:9
Structures of new friedelane-type triterpenes and eudesmane-type sesquiterpene and aldose reductase inhibitors from Salacia chinensis.
AID313986Inhibition of tubulin polymerization2008Bioorganic & medicinal chemistry letters, Feb-01, Volume: 18, Issue:3
Antimitotic quinoid triterpenes from Maytenus chuchuhuasca.
AID566859Cytotoxicity against human MCF7 cells at 30 uM after 48 hrs by MTT assay2010Journal of natural products, Dec-27, Volume: 73, Issue:12
Cytotoxic triterpenoids from Maytenus retusa.
AID359903Cytotoxicity against mouse P388 cells by MTT assay1994Journal of natural products, Dec, Volume: 57, Issue:12
Cytotoxic aromatic triterpenes from Maytenus ilicifolia and Maytenus chuchuhuasca.
AID566857Cytotoxicity against human MCF7 cells at 1 uM after 48 hrs by MTT assay2010Journal of natural products, Dec-27, Volume: 73, Issue:12
Cytotoxic triterpenoids from Maytenus retusa.
AID566854Cytotoxicity against human HL60 cells at 1 uM after 48 hrs by MTT assay2010Journal of natural products, Dec-27, Volume: 73, Issue:12
Cytotoxic triterpenoids from Maytenus retusa.
AID566779Cytotoxicity against human HL60 cells after 48 hrs by MTT assay2010Journal of natural products, Dec-27, Volume: 73, Issue:12
Cytotoxic triterpenoids from Maytenus retusa.
AID566855Cytotoxicity against human HL60 cells at 10 uM after 48 hrs by MTT assay2010Journal of natural products, Dec-27, Volume: 73, Issue:12
Cytotoxic triterpenoids from Maytenus retusa.
AID566858Cytotoxicity against human MCF7 cells at 10 uM after 48 hrs by MTT assay2010Journal of natural products, Dec-27, Volume: 73, Issue:12
Cytotoxic triterpenoids from Maytenus retusa.
AID566853Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay2010Journal of natural products, Dec-27, Volume: 73, Issue:12
Cytotoxic triterpenoids from Maytenus retusa.
AID397122Inhibition of HIV1 RT
AID313987Growth inhibition of human RPMI8226 cells2008Bioorganic & medicinal chemistry letters, Feb-01, Volume: 18, Issue:3
Antimitotic quinoid triterpenes from Maytenus chuchuhuasca.
AID566856Cytotoxicity against human HL60 cells at 30 uM after 48 hrs by MTT assay2010Journal of natural products, Dec-27, Volume: 73, Issue:12
Cytotoxic triterpenoids from Maytenus retusa.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (22.22)18.2507
2000's2 (22.22)29.6817
2010's2 (22.22)24.3611
2020's3 (33.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.40

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.40 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.80 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.40)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]